Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Takayasu arteritis].

Thomas Quéméneur1, Eric Hachulla, Marc Lambert

  • 1Service de médecine interne, Hôpital Claude Huriez, CHU Lille (59).

Presse Medicale (Paris, France : 1983)
|May 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, biological and cytometric characteristics of two patients with a homozygous A91V<i>PRF1</i> mutation.

Clinical & translational immunology·2026
Same author

Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.

Pulmonology·2026
Same author

The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa).

American journal of hematology·2026
Same author

Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort study.

Journal of critical care·2026
Same author

Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.

Arthritis research & therapy·2026
Same author

Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.

Journal of autoimmunity·2026
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Takayasu arteritis is a large vessel inflammatory disease affecting the aorta. Diagnosis relies on imaging, and treatment involves corticosteroids and immunosuppressants, with surgery for severe cases.

Area of Science:

  • Inflammatory arteritis affecting large vessels, primarily the aorta and its branches.

Context:

  • Takayasu arteritis presents with vessel wall thickening, leading to stenosis, thrombosis, or aneurysms.
  • Incidence is 1.2-2.6/million/year, predominantly affecting women aged 20-40.
  • Clinical manifestations are diverse, ranging from asymptomatic cases to severe neurological events.

Purpose:

  • To summarize the current understanding of Takayasu arteritis, including its pathology, diagnosis, and treatment.
  • To highlight the limitations in current diagnostic and treatment protocols and the need for evidence-based medicine.

Summary:

  • Diagnosis relies on imaging techniques like Doppler ultrasound, CT, and MRI for anatomical assessment.
  • Positron emission tomography (PET) is highly sensitive for detecting disease activity, as standard inflammatory markers are often ineffective.

Related Experiment Videos

  • Treatment typically involves corticosteroids, with methotrexate as a second-line option. Surgical or endovascular interventions may be required for critical ischemia or aneurysms.

    • Impact:

    • Current treatment strategies for Takayasu arteritis are largely experience-based, necessitating multicenter studies.
    • Establishing evidence-based guidelines is crucial for optimizing treatment duration, second-line therapy selection, and medication tapering protocols.